medwireNews: Inhaled colistimethate sodium could help prevent exacerbations in patients with bronchiectasis and Pseudomonas aeruginosa infection, suggest findings from the phase 3 PROMIS-I trial.
19-09-2024 | Bronchiectasis | Editor's Choice | News
19-09-2024 | Bronchiectasis | Editor's Choice | News
medwireNews: Inhaled colistimethate sodium could help prevent exacerbations in patients with bronchiectasis and Pseudomonas aeruginosa infection, suggest findings from the phase 3 PROMIS-I trial.